1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Analyzers/Instruments 1.2.3 Kits/Panels 1.3 Market by Application 1.3.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Clostridium Difficile 1.3.3 Campylobacteriosis 1.3.4 Cholera 1.3.5 E. coli Infection 1.3.6 H. pylori Infection 1.3.7 Salmonellosis 1.3.8 Shigellosis 1.3.9 Rotavirus Infection 1.3.10 Norovirus Infection 1.3.11 Parasitic Enteric Disease 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global PCR-based Enteric Disease Testing Market Perspective (2017-2028) 2.2 PCR-based Enteric Disease Testing Growth Trends by Region 2.2.1 PCR-based Enteric Disease Testing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 PCR-based Enteric Disease Testing Historic Market Size by Region (2017-2022) 2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Region (2023-2028) 2.3 PCR-based Enteric Disease Testing Market Dynamics 2.3.1 PCR-based Enteric Disease Testing Industry Trends 2.3.2 PCR-based Enteric Disease Testing Market Drivers 2.3.3 PCR-based Enteric Disease Testing Market Challenges 2.3.4 PCR-based Enteric Disease Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top PCR-based Enteric Disease Testing Players by Revenue 3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2017-2022) 3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2017-2022) 3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue 3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio 3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2021 3.5 PCR-based Enteric Disease Testing Key Players Head office and Area Served 3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service 3.7 Date of Enter into PCR-based Enteric Disease Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 PCR-based Enteric Disease Testing Breakdown Data by Type 4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2017-2022) 4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2023-2028) 5 PCR-based Enteric Disease Testing Breakdown Data by Application 5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2017-2022) 5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America PCR-based Enteric Disease Testing Market Size (2017-2028) 6.2 North America PCR-based Enteric Disease Testing Market Size by Type 6.2.1 North America PCR-based Enteric Disease Testing Market Size by Type (2017-2022) 6.2.2 North America PCR-based Enteric Disease Testing Market Size by Type (2023-2028) 6.2.3 North America PCR-based Enteric Disease Testing Market Share by Type (2017-2028) 6.3 North America PCR-based Enteric Disease Testing Market Size by Application 6.3.1 North America PCR-based Enteric Disease Testing Market Size by Application (2017-2022) 6.3.2 North America PCR-based Enteric Disease Testing Market Size by Application (2023-2028) 6.3.3 North America PCR-based Enteric Disease Testing Market Share by Application (2017-2028) 6.4 North America PCR-based Enteric Disease Testing Market Size by Country 6.4.1 North America PCR-based Enteric Disease Testing Market Size by Country (2017-2022) 6.4.2 North America PCR-based Enteric Disease Testing Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe PCR-based Enteric Disease Testing Market Size (2017-2028) 7.2 Europe PCR-based Enteric Disease Testing Market Size by Type 7.2.1 Europe PCR-based Enteric Disease Testing Market Size by Type (2017-2022) 7.2.2 Europe PCR-based Enteric Disease Testing Market Size by Type (2023-2028) 7.2.3 Europe PCR-based Enteric Disease Testing Market Share by Type (2017-2028) 7.3 Europe PCR-based Enteric Disease Testing Market Size by Application 7.3.1 Europe PCR-based Enteric Disease Testing Market Size by Application (2017-2022) 7.3.2 Europe PCR-based Enteric Disease Testing Market Size by Application (2023-2028) 7.3.3 Europe PCR-based Enteric Disease Testing Market Share by Application (2017-2028) 7.4 Europe PCR-based Enteric Disease Testing Market Size by Country 7.4.1 Europe PCR-based Enteric Disease Testing Market Size by Country (2017-2022) 7.4.2 Europe PCR-based Enteric Disease Testing Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size (2017-2028) 8.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type 8.2.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2017-2022) 8.2.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2023-2028) 8.2.3 Asia-Pacific PCR-based Enteric Disease Testing Market Share by Type (2017-2028) 8.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application 8.3.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2017-2022) 8.3.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2023-2028) 8.3.3 Asia-Pacific PCR-based Enteric Disease Testing Market Share by Application (2017-2028) 8.4 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region 8.4.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2017-2022) 8.4.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America PCR-based Enteric Disease Testing Market Size (2017-2028) 9.2 Latin America PCR-based Enteric Disease Testing Market Size by Type 9.2.1 Latin America PCR-based Enteric Disease Testing Market Size by Type (2017-2022) 9.2.2 Latin America PCR-based Enteric Disease Testing Market Size by Type (2023-2028) 9.2.3 Latin America PCR-based Enteric Disease Testing Market Share by Type (2017-2028) 9.3 Latin America PCR-based Enteric Disease Testing Market Size by Application 9.3.1 Latin America PCR-based Enteric Disease Testing Market Size by Application (2017-2022) 9.3.2 Latin America PCR-based Enteric Disease Testing Market Size by Application (2023-2028) 9.3.3 Latin America PCR-based Enteric Disease Testing Market Share by Application (2017-2028) 9.4 Latin America PCR-based Enteric Disease Testing Market Size by Country 9.4.1 Latin America PCR-based Enteric Disease Testing Market Size by Country (2017-2022) 9.4.2 Latin America PCR-based Enteric Disease Testing Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size (2017-2028) 10.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type 10.2.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2017-2022) 10.2.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2023-2028) 10.2.3 Middle East & Africa PCR-based Enteric Disease Testing Market Share by Type (2017-2028) 10.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application 10.3.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2017-2022) 10.3.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2023-2028) 10.3.3 Middle East & Africa PCR-based Enteric Disease Testing Market Share by Application (2017-2028) 10.4 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country 10.4.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2017-2022) 10.4.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Details 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction 11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.1.5 Thermo Fisher Scientific Recent Developments 11.2 Vela Diagnostics 11.2.1 Vela Diagnostics Company Details 11.2.2 Vela Diagnostics Business Overview 11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction 11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.2.5 Vela Diagnostics Recent Developments 11.3 CorisBioconcept 11.3.1 CorisBioconcept Company Details 11.3.2 CorisBioconcept Business Overview 11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction 11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.3.5 CorisBioconcept Recent Developments 11.4 Meridian Life Science 11.4.1 Meridian Life Science Company Details 11.4.2 Meridian Life Science Business Overview 11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction 11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.4.5 Meridian Life Science Recent Developments 11.5 Bio-Rad Laboratories 11.5.1 Bio-Rad Laboratories Company Details 11.5.2 Bio-Rad Laboratories Business Overview 11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction 11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.5.5 Bio-Rad Laboratories Recent Developments 11.6 Abbott (ALERE) 11.6.1 Abbott (ALERE) Company Details 11.6.2 Abbott (ALERE) Business Overview 11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction 11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.6.5 Abbott (ALERE) Recent Developments 11.7 bioMerieux SA 11.7.1 bioMerieux SA Company Details 11.7.2 bioMerieux SA Business Overview 11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction 11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.7.5 bioMerieux SA Recent Developments 11.8 Trinity Biotech 11.8.1 Trinity Biotech Company Details 11.8.2 Trinity Biotech Business Overview 11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction 11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.8.5 Trinity Biotech Recent Developments 11.9 DiaSorin Molecular 11.9.1 DiaSorin Molecular Company Details 11.9.2 DiaSorin Molecular Business Overview 11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction 11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.9.5 DiaSorin Molecular Recent Developments 11.10 Etta Healthcare (Ovagene Oncology) 11.10.1 Etta Healthcare (Ovagene Oncology) Company Details 11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview 11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction 11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.10.5 Etta Healthcare (Ovagene Oncology) Recent Developments 11.11 ExcitePCR (PositiveID Corporation) 11.11.1 ExcitePCR (PositiveID Corporation) Company Details 11.11.2 ExcitePCR (PositiveID Corporation) Business Overview 11.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction 11.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.11.5 ExcitePCR (PositiveID Corporation) Recent Developments 11.12 Flow Alliance 11.12.1 Flow Alliance Company Details 11.12.2 Flow Alliance Business Overview 11.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction 11.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.12.5 Flow Alliance Recent Developments 11.13 Fluid-Screen 11.13.1 Fluid-Screen Company Details 11.13.2 Fluid-Screen Business Overview 11.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction 11.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.13.5 Fluid-Screen Recent Developments 11.14 FluimediX 11.14.1 FluimediX Company Details 11.14.2 FluimediX Business Overview 11.14.3 FluimediX PCR-based Enteric Disease Testing Introduction 11.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.14.5 FluimediX Recent Developments 11.15 Fluxergy 11.15.1 Fluxergy Company Details 11.15.2 Fluxergy Business Overview 11.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction 11.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.15.5 Fluxergy Recent Developments 11.16 Focus Diagnostics (DiaSorin Molecular) 11.16.1 Focus Diagnostics (DiaSorin Molecular) Company Details 11.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview 11.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction 11.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Developments 11.17 Future Horizon Scientific 11.17.1 Future Horizon Scientific Company Details 11.17.2 Future Horizon Scientific Business Overview 11.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction 11.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.17.5 Future Horizon Scientific Recent Developments 11.18 Genalyte 11.18.1 Genalyte Company Details 11.18.2 Genalyte Business Overview 11.18.3 Genalyte PCR-based Enteric Disease Testing Introduction 11.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.18.5 Genalyte Recent Developments 11.19 GeneFluidics 11.19.1 GeneFluidics Company Details 11.19.2 GeneFluidics Business Overview 11.19.3 GeneFluidics PCR-based Enteric Disease Testing Introduction 11.19.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.19.5 GeneFluidics Recent Developments 11.20 GenSpeed Biotech 11.20.1 GenSpeed Biotech Company Details 11.20.2 GenSpeed Biotech Business Overview 11.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction 11.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.20.5 GenSpeed Biotech Recent Developments 11.21 Gulf Bio Analytical 11.21.1 Gulf Bio Analytical Company Details 11.21.2 Gulf Bio Analytical Business Overview 11.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction 11.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.21.5 Gulf Bio Analytical Recent Developments 11.22 Hahn-Schickard 11.22.1 Hahn-Schickard Company Details 11.22.2 Hahn-Schickard Business Overview 11.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction 11.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.22.5 Hahn-Schickard Recent Developments 11.23 Helvoet 11.23.1 Helvoet Company Details 11.23.2 Helvoet Business Overview 11.23.3 Helvoet PCR-based Enteric Disease Testing Introduction 11.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.23.5 Helvoet Recent Developments 11.24 HemoCue 11.24.1 HemoCue Company Details 11.24.2 HemoCue Business Overview 11.24.3 HemoCue PCR-based Enteric Disease Testing Introduction 11.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.24.5 HemoCue Recent Developments 11.25 Danaher 11.25.1 Danaher Company Details 11.25.2 Danaher Business Overview 11.25.3 Danaher PCR-based Enteric Disease Testing Introduction 11.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.25.5 Danaher Recent Developments 11.26 IDEX Health&Science 11.26.1 IDEX Health&Science Company Details 11.26.2 IDEX Health&Science Business Overview 11.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction 11.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.26.5 IDEX Health&Science Recent Developments 11.27 iLine Microsystems 11.27.1 iLine Microsystems Company Details 11.27.2 iLine Microsystems Business Overview 11.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction 11.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.27.5 iLine Microsystems Recent Developments 11.28 Inflammatix 11.28.1 Inflammatix Company Details 11.28.2 Inflammatix Business Overview 11.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction 11.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2017-2022) 11.28.5 Inflammatix Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Analyzers/Instruments Table 3. Key Players of Kits/Panels Table 4. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global PCR-based Enteric Disease Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global PCR-based Enteric Disease Testing Market Size by Region (2017-2022) & (US$ Million) Table 7. Global PCR-based Enteric Disease Testing Market Share by Region (2017-2022) Table 8. Global PCR-based Enteric Disease Testing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global PCR-based Enteric Disease Testing Market Share by Region (2023-2028) Table 10. PCR-based Enteric Disease Testing Market Trends Table 11. PCR-based Enteric Disease Testing Market Drivers Table 12. PCR-based Enteric Disease Testing Market Challenges Table 13. PCR-based Enteric Disease Testing Market Restraints Table 14. Global PCR-based Enteric Disease Testing Revenue by Players (2017-2022) & (US$ Million) Table 15. Global PCR-based Enteric Disease Testing Revenue Share by Players (2017-2022) Table 16. Global Top PCR-based Enteric Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2021) Table 17. Ranking of Global Top PCR-based Enteric Disease Testing Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by PCR-based Enteric Disease Testing Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players PCR-based Enteric Disease Testing Product Solution and Service Table 21. Date of Enter into PCR-based Enteric Disease Testing Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million) Table 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2017-2022) Table 25. Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2023-2028) Table 27. Global PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million) Table 28. Global PCR-based Enteric Disease Testing Revenue Share by Application (2017-2022) Table 29. Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global PCR-based Enteric Disease Testing Revenue Share by Application (2023-2028) Table 31. North America PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million) Table 32. North America PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million) Table 33. North America PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million) Table 34. North America PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million) Table 35. North America PCR-based Enteric Disease Testing Market Size by Country (2017-2022) & (US$ Million) Table 36. North America PCR-based Enteric Disease Testing Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe PCR-based Enteric Disease Testing Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe PCR-based Enteric Disease Testing Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific PCR-based Enteric Disease Testing Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific PCR-based Enteric Disease Testing Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America PCR-based Enteric Disease Testing Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America PCR-based Enteric Disease Testing Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Country (2023-2028) & (US$ Million) Table 61. Thermo Fisher Scientific Company Details Table 62. Thermo Fisher Scientific Business Overview Table 63. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product Table 64. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 65. Thermo Fisher Scientific Recent Developments Table 66. Vela Diagnostics Company Details Table 67. Vela Diagnostics Business Overview Table 68. Vela Diagnostics PCR-based Enteric Disease Testing Product Table 69. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 70. Vela Diagnostics Recent Developments Table 71. CorisBioconcept Company Details Table 72. CorisBioconcept Business Overview Table 73. CorisBioconcept PCR-based Enteric Disease Testing Product Table 74. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 75. CorisBioconcept Recent Developments Table 76. Meridian Life Science Company Details Table 77. Meridian Life Science Business Overview Table 78. Meridian Life Science PCR-based Enteric Disease Testing Product Table 79. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 80. Meridian Life Science Recent Developments Table 81. Bio-Rad Laboratories Company Details Table 82. Bio-Rad Laboratories Business Overview Table 83. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product Table 84. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 85. Bio-Rad Laboratories Recent Developments Table 86. Abbott (ALERE) Company Details Table 87. Abbott (ALERE) Business Overview Table 88. Abbott (ALERE) PCR-based Enteric Disease Testing Product Table 89. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 90. Abbott (ALERE) Recent Developments Table 91. bioMerieux SA Company Details Table 92. bioMerieux SA Business Overview Table 93. bioMerieux SA PCR-based Enteric Disease Testing Product Table 94. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 95. bioMerieux SA Recent Developments Table 96. Trinity Biotech Company Details Table 97. Trinity Biotech Business Overview Table 98. Trinity Biotech PCR-based Enteric Disease Testing Product Table 99. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 100. Trinity Biotech Recent Developments Table 101. DiaSorin Molecular Company Details Table 102. DiaSorin Molecular Business Overview Table 103. DiaSorin Molecular PCR-based Enteric Disease Testing Product Table 104. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 105. DiaSorin Molecular Recent Developments Table 106. Etta Healthcare (Ovagene Oncology) Company Details Table 107. Etta Healthcare (Ovagene Oncology) Business Overview Table 108. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product Table 109. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 110. Etta Healthcare (Ovagene Oncology) Recent Developments Table 111. ExcitePCR (PositiveID Corporation) Company Details Table 112. ExcitePCR (PositiveID Corporation) Business Overview Table 113. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product Table 114. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 115. ExcitePCR (PositiveID Corporation) Recent Developments Table 116. Flow Alliance Company Details Table 117. Flow Alliance Business Overview Table 118. Flow Alliance PCR-based Enteric Disease Testing Product Table 119. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 120. Flow Alliance Recent Developments Table 121. Fluid-Screen Company Details Table 122. Fluid-Screen Business Overview Table 123. Fluid-Screen PCR-based Enteric Disease Testing Product Table 124. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 125. Fluid-Screen Recent Developments Table 126. FluimediX Company Details Table 127. FluimediX Business Overview Table 128. FluimediX PCR-based Enteric Disease Testing Product Table 129. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 130. FluimediX Recent Developments Table 131. Fluxergy Company Details Table 132. Fluxergy Business Overview Table 133. Fluxergy PCR-based Enteric Disease Testing Product Table 134. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 135. Fluxergy Recent Developments Table 136. Focus Diagnostics (DiaSorin Molecular) Company Details Table 137. Focus Diagnostics (DiaSorin Molecular) Business Overview Table 138. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product Table 139. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 140. Focus Diagnostics (DiaSorin Molecular) Recent Developments Table 141. Future Horizon Scientific Company Details Table 142. Future Horizon Scientific Business Overview Table 143. Future Horizon Scientific PCR-based Enteric Disease Testing Product Table 144. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 145. Future Horizon Scientific Recent Developments Table 146. Genalyte Company Details Table 147. Genalyte Business Overview Table 148. Genalyte PCR-based Enteric Disease Testing Product Table 149. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 150. Genalyte Recent Developments Table 151. GeneFluidics Company Details Table 152. GeneFluidics Business Overview Table 153. GeneFluidics PCR-based Enteric Disease Testing Product Table 154. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 155. GeneFluidics Recent Developments Table 156. GenSpeed Biotech Company Details Table 157. GenSpeed Biotech Business Overview Table 158. GenSpeed Biotech PCR-based Enteric Disease Testing Product Table 159. GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 160. GenSpeed Biotech Recent Developments Table 161. Gulf Bio Analytical Company Details Table 162. Gulf Bio Analytical Business Overview Table 163. Gulf Bio Analytical PCR-based Enteric Disease Testing Product Table 164. Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 165. Gulf Bio Analytical Recent Developments Table 166. Hahn-Schickard Company Details Table 167. Hahn-Schickard Business Overview Table 168. Hahn-Schickard PCR-based Enteric Disease Testing Product Table 169. Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 170. Hahn-Schickard Recent Developments Table 171. Helvoet Company Details Table 172. Helvoet Business Overview Table 173. Helvoet PCR-based Enteric Disease Testing Product Table 174. Helvoet Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 175. Helvoet Recent Developments Table 176. HemoCue Company Details Table 177. HemoCue Business Overview Table 178. HemoCue PCR-based Enteric Disease Testing Product Table 179. HemoCue Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 180. HemoCue Recent Developments Table 181. Danaher Company Details Table 182. Danaher Business Overview Table 183. Danaher PCR-based Enteric Disease Testing Product Table 184. Danaher Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 185. Danaher Recent Developments Table 186. IDEX Health&Science Company Details Table 187. IDEX Health&Science Business Overview Table 188. IDEX Health&Science PCR-based Enteric Disease Testing Product Table 189. IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 190. IDEX Health&Science Recent Developments Table 191. iLine Microsystems Company Details Table 192. iLine Microsystems Business Overview Table 193. iLine Microsystems PCR-based Enteric Disease Testing Product Table 194. iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 195. iLine Microsystems Recent Developments Table 196. Inflammatix Company Details Table 197. Inflammatix Business Overview Table 198. Inflammatix PCR-based Enteric Disease Testing Product Table 199. Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Table 200. Inflammatix Recent Developments Table 201. Research Programs/Design for This Report Table 202. Key Data Information from Secondary Sources Table 203. Key Data Information from Primary Sources List of Figures Figure 1. Global PCR-based Enteric Disease Testing Market Share by Type: 2021 VS 2028 Figure 2. Analyzers/Instruments Features Figure 3. Kits/Panels Features Figure 4. Global PCR-based Enteric Disease Testing Market Share by Application: 2021 VS 2028 Figure 5. Clostridium Difficile Case Studies Figure 6. Campylobacteriosis Case Studies Figure 7. Cholera Case Studies Figure 8. E. coli Infection Case Studies Figure 9. H. pylori Infection Case Studies Figure 10. Salmonellosis Case Studies Figure 11. Shigellosis Case Studies Figure 12. Rotavirus Infection Case Studies Figure 13. Norovirus Infection Case Studies Figure 14. Parasitic Enteric Disease Case Studies Figure 15. PCR-based Enteric Disease Testing Report Years Considered Figure 16. Global PCR-based Enteric Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 17. Global PCR-based Enteric Disease Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 18. Global PCR-based Enteric Disease Testing Market Share by Region: 2021 VS 2028 Figure 19. Global PCR-based Enteric Disease Testing Market Share by Players in 2021 Figure 20. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2021) Figure 21. The Top 10 and 5 Players Market Share by PCR-based Enteric Disease Testing Revenue in 2021 Figure 22. North America PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million) Figure 23. North America PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028) Figure 24. North America PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028) Figure 25. North America PCR-based Enteric Disease Testing Market Size Share by Country (2017-2028) Figure 26. United States PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Canada PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Europe PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million) Figure 29. Europe PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028) Figure 30. Europe PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028) Figure 31. Europe PCR-based Enteric Disease Testing Market Size Share by Country (2017-2028) Figure 32. Germany PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. France PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. U.K. PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Italy PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Russia PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Nordic Countries PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million) Figure 39. Asia Pacific PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028) Figure 40. Asia Pacific PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028) Figure 41. Asia Pacific PCR-based Enteric Disease Testing Market Size Share by Region (2017-2028) Figure 42. China PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Japan PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. South Korea PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Southeast Asia PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. India PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Australia PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 48. Latin America PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million) Figure 49. Latin America PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028) Figure 50. Latin America PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028) Figure 51. Latin America PCR-based Enteric Disease Testing Market Size Share by Country (2017-2028) Figure 52. Mexico PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Brazil PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Middle East & Africa PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million) Figure 55. Middle East and Africa PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028) Figure 56. Middle East and Africa PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028) Figure 57. Middle East and Africa PCR-based Enteric Disease Testing Market Size Share by Country (2017-2028) Figure 58. Turkey PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 59. Saudi Arabia PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 60. UAE PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 61. Thermo Fisher Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 62. Vela Diagnostics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 63. CorisBioconcept Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 64. Meridian Life Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 65. Bio-Rad Laboratories Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 66. Abbott (ALERE) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 67. bioMerieux SA Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 68. Trinity Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 69. DiaSorin Molecular Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 70. Etta Healthcare (Ovagene Oncology) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 71. ExcitePCR (PositiveID Corporation) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 72. Flow Alliance Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 73. Fluid-Screen Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 74. FluimediX Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 75. Fluxergy Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 76. Focus Diagnostics (DiaSorin Molecular) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 77. Future Horizon Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 78. Genalyte Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 79. GeneFluidics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 80. GenSpeed Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 81. Gulf Bio Analytical Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 82. Hahn-Schickard Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 83. Helvoet Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 84. HemoCue Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 85. Danaher Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 86. IDEX Health&Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 87. iLine Microsystems Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 88. Inflammatix Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022) Figure 89. Bottom-up and Top-down Approaches for This Report Figure 90. Data Triangulation Figure 91. Key Executives Interviewed

Thermo Fisher Scientific Vela Diagnostics CorisBioconcept Meridian Life Science Bio-Rad Laboratories Abbott (ALERE) bioMerieux SA Trinity Biotech DiaSorin Molecular Etta Healthcare (Ovagene Oncology) ExcitePCR (PositiveID Corporation) Flow Alliance Fluid-Screen FluimediX Fluxergy Focus Diagnostics (DiaSorin Molecular) Future Horizon Scientific Genalyte GeneFluidics GenSpeed Biotech Gulf Bio Analytical Hahn-Schickard Helvoet HemoCue Danaher IDEX Health&Science iLine Microsystems Inflammatix